This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Next Week's Game Plan

Tesaro is an oncology-focused company that aims to help improve the lives of cancer patients. It's first drug, Rolapitant, was licensed from Opko Health (OPK) for a terrific price and is now in Phase III testing. That drug helps prevent nausea in patients undergoing chemotherapy.

Tesaro also has two other drugs in early stage testing, one to directly attack tumors and the other to treat specific lung cancers. With over $138 million in cash on its books and no debt, Cramer said that Tesaro is really a $10 stock with a very promising future.

A Veteran of Many Battles

In the "Executive Decision" segment, Cramer sat down with Bob Benmoche, president and CEO of American International Group (AIG), as well as veteran of the Vietnam war.

Benmoche said that one of the things his military service taught him was leadership and taking responsibility for the people who serve under him. This training came in handy at AIG, he said, as he has to instill confidence in its employees, its customers and its shareholders.

Looking back at the financial crisis, Benmoche said AIG's problem was not necessarily with bad loans but liquidity. He said the company simply didn't have enough cash. Had AIG had access to the same resources banks did, he feels the company would not have needed bailout money. The value of AIG's assets, he said, was actually OK, which is why the U.S. government has been able to sell some of its stake for a profit.

Benmoche said the government still owns 15.9% of AIG, but has been making smart divestitures and will not disrupt other shareholders as it continues to exit. AIG remains committed to its $13 billion stock buyback program to help protect current shareholders, and the company is also working to improve its credit rating.

Turning to Hurricane Sandy, Benmoche called it a significant event that AIG can handle. He said the focus at the moment is paying claims to those in need as quickly as possible.

Cramer thanked Benmoche for his military service and continued to recommend AIG's stock.

Lightning Round

In the Lightning Round, Cramer was bullish on Nordstrom (JWN), Harley-Davidson (HOG), Microsoft (MSFT), Yahoo! (YHOO), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Chevron (CVX) and Wynn Resorts (WYNN).

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs